UBS Balanced Investment Fund is an Managed Funds investment product that is benchmarked against Multi-Asset Growth Investor Index and sits inside the Multi-Asset - 61-80% Diversified Index. Think of a benchmark as a standard where investment performance can be measured. Typically, market indices like the ASX200 and market-segment stock indexes are used for this purpose. The UBS Balanced Investment Fund has Assets Under Management of 774.50 M with a management fee of 0.95%, a performance fee of 0 and a buy/sell spread fee of 0.4%.
The recent investment performance of the investment product shows that the UBS Balanced Investment Fund has returned 1.41% in the last month. The previous three years have returned 2.06% annualised and 7.9% each year since inception, which is when the UBS Balanced Investment Fund first started.
There are many ways that the risk of an investment product can be measured, and each measurement provides a different insight into the risk present. They can be used on their own or together to perform a risk assessment before investing, but when comparing investments, it is common to compare like for like risk measurements to determine which investment holds the most risk. Since UBS Balanced Investment Fund first started, the Sharpe ratio is NA with an annualised volatility of 7.9%. The maximum drawdown of the investment product in the last 12 months is -2.37% and -30.48% since inception. The maximum drawdown is defined as the high-to-low decline of an investment during a particular time period.
Relative performance is what an asset achieves over a period of time compared to similar investments or its peers. Relative return is a measure of the asset's performance compared to the return to the other investment. The UBS Balanced Investment Fund has a 12-month excess return when compared to the Multi-Asset - 61-80% Diversified Index of -1.93% and -0.37% since inception.
Alpha is an investing term used to measure an investment's outperformance relative to a market benchmark or peer investment. Alpha describes the excess return generated when compared to peer investment. UBS Balanced Investment Fund has produced Alpha over the Multi-Asset - 61-80% Diversified Index of NA% in the last 12 months and NA% since inception.
For a full list of investment products in the Multi-Asset - 61-80% Diversified Index category, you can click here for the Peer Investment Report.
UBS Balanced Investment Fund has a correlation coefficient of 0.96 and a beta of 0.94 when compared to the Multi-Asset - 61-80% Diversified Index. Correlation measures how similarly two investments move in relation to one another. This establishes a 'correlation coefficient', which has a value between -1.0 and +1.0. A 100% correlation between two investments means that the correlation coefficient is +1. Beta in investments measures how much the price moves relative to the broader market over a period of time. If the investment moves more than the broader market, it has a beta above 1.0. If it moves less than the broader market, then the beta is less than 1.0. Investments with a high beta tend to carry more risk but have the potential to deliver higher returns.
For a full quantitative report on UBS Balanced Investment Fund and its peer investments, you can click here for the Peer Investment Report.
For a full quantitative report on UBS Balanced Investment Fund compared to the Multi-Asset Growth Investor Index, you can click here.
To sort and compare the UBS Balanced Investment Fund financial metrics, please refer to the table above.
This investment product is in the process of being independently verified by SMSF Mate. Once we have verified the investment product, you will be able to find more information here.
SMSF Mate does not receive commissions or kickbacks from the UBS Balanced Investment Fund. All data and commentary for this fund is provided free of charge for our readers general information.
After fees and expenses, the portfolio returned -0.44% (gross of fees return of -0.36%) in August which underperformed its benchmark return of 0.09% by 53bps. At the end of August, the Fund’s equity weight was 2.6% overweight relative to the benchmark. Foreign currency exposure was at 30.5% with key underweight in CNH, NZD, AUD, GBP, and EUR as well as overweight in MXN, JPY, BRL, COP and NOK.
After fees and expenses, the portfolio returned 1.93% (gross of fees return of 2.01%) in July which outperformed its benchmark return of 1.85% by 8bps. At the end of July, the Fund’s equity weight was 2.6% overweight relative to the benchmark.
Foreign currency exposure was at 28.9% with key underweight in CNH, NZD, USD, GBP and EUR as well as overweight in MXN, JPY, BRL, AUD, COP and NOK.
After fees and expenses, the portfolio returned 1.16% (gross of fees return of 1.24%) in June which underperformed its benchmark return of 1.36% by 20bps. At the end of June, the Fund’s equity weight was 2.3% overweight relative to the benchmark as we introduced an overweight position to equity in mid June.
Foreign currency exposure was at 29.4% with key underweight in CNH, NZDand USD as well as overweight in MXN, JPY, BRL and AUD.
After fees and expenses, the portfolio returned -1.38% (gross of fees return of -1.3%) in May which underperformed its benchmark return of -0.75% by 63bps. At the end of May, the Fund’s equity weight was 0.3% overweight relative to the benchmark as we closed our directional underweight to equities at the end of the month.
Foreign currency exposure was at 28.3% with key underweights in CNH, NZD, USD and overweight in AUD, JPY, MXN, and BRL.
After fees and expenses, the portfolio returned 1.55% (gross of fees return of 1.62%) in April which underperformed its benchmark return of 1.61% by 6bps. At the end of April, the Fund’s equity weight was -3.3% underweight relative to the benchmark as we retained our directional underweight to equities throughout the month.
Foreign currency exposure was at 29% with key underweights in USD, NZD, KRW and GBP and overweight in JPY, MXN, AUD, BRL and EUR.
After fees and expenses, the portfolio returned 0.87% (gross of fees return of 0.96%) in March which underperformed its benchmark return of 1.47% by 60bps. At the end of March, the Fund’s equity weight was -4% underweight relative to the benchmark as we marginally increased the directional underweight to equities for downside protection, amid market turbulence brought by the negative news from financial sectors over the month.
Foreign currency exposure was at 29.1% with key underweights in USD, NZD, KRW and GBP and overweight in JPY, MXN, AUD, BRL and EUR.
After fees and expenses, the portfolio returned -1.29% (gross of fees return of -1.21%) in February which underperformed its benchmark return of -0.75% by 54bps. At the end of February, the Fund’s equity weight was -3.1% underweight relative to the benchmark as we retained a small underweight to equities in aggregate throughout the month.
Foreign currency exposure was at 27.8% with key underweights in USD, GBP, NZD, EUR and KRW and overweight in JPY, MXN, AUD, NOK and BRL.
Product Snapshot
Product Overview
Performance Review
Peer Comparison
Product Details